%0 Generic
%T Bone metabolism biomarkers (BMB) and progression-free survival (PFS) in men with metastatic hormone-sensitive prostate cancer (HSPC): SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) with or without orteronel.
%A Lara, Primo
%A Mayerson, Edward
%A Gertz, Erik
%A Tangen, Catherine
%A Goldkorn, Amir
%A Van Loan, Marta
%A Hussain, Maha H. A.
%A Gupta, Shilpa
%A Zhang, Jingsong
%A Twardowski, Przemyslaw
%A Quinn, David I.
%A Vogelzang, Nicholas J.
%A Thompson, Ian Murchie
%A Agarwal, Neeraj
%I American Society of Clinical Oncology (ASCO)
%@ 1527-7755
%@ 0732-183X
%K Cancer Research
%K Oncology
%D 2020
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation